Question 1

How big is the Global Nuclear Medicine Isotopes market?

Accepted Answer

According to Value Market Research, the Global Nuclear Medicine Isotopes market size was estimated at USD 8.28 Billion in 2025 and is expected to reach USD 8.87 Billion in 2026.

Question 2

What is the Global Nuclear Medicine Isotopes market growth?

Accepted Answer

The Global Nuclear Medicine Isotopes market is expected to grow at a CAGR of 7.17% from 2026-2034 to reach USD 15.44 Billion by 2034.

Question 3

Which country holds the highest share in the Global Nuclear Medicine Isotopes market?

Accepted Answer

North America held the highest share in the Global Nuclear Medicine Isotopes market.

Question 4

How is the Global Nuclear Medicine Isotopes market segmented in the report?

Accepted Answer

The Global Nuclear Medicine Isotopes market is segmented By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Beta Emitters, Alpha Emitters, Brachytherapy Isotopes, Stable Isotopes, Radioisotopes), By Application (Nuclear Therapy, Equipment Radioactive Source, Diagnosis), By End Use (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutions, Others).

Question 5

Who are the key players in the Global Nuclear Medicine Isotopes market?

Accepted Answer

Some key players include Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging and Nordion.

Question 6

What are the factors driving the nuclear medicine isotopes market?

Accepted Answer

Key drivers include the rising prevalence of cancer and cardiovascular diseases, increasing demand for diagnostic imaging procedures, technological advancements in radiopharmaceuticals, and growing adoption of PET and SPECT imaging in clinical diagnosis and treatment monitoring.

Question 7

Which segment accounted for the largest nuclear medicine isotopes market share?

Accepted Answer

Hospitals dominated the market with a share of 60.94% in 2025, driven by the availability of advanced imaging infrastructure, increasing patient volume for diagnostic procedures, skilled healthcare professionals, and growing adoption of nuclear medicine for disease diagnosis and treatment.